172 related articles for article (PubMed ID: 15916483)
41. Regulation of the lifespan in dendritic cell subsets.
Chen M; Huang L; Shabier Z; Wang J
Mol Immunol; 2007 Apr; 44(10):2558-65. PubMed ID: 17267035
[TBL] [Abstract][Full Text] [Related]
42. Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells.
De Bruijn ML; Schuurhuis DH; Vierboom MP; Vermeulen H; de Cock KA; Ooms ME; Ressing ME; Toebes M; Franken KL; Drijfhout JW; Ottenhoff TH; Offringa R; Melief CJ
Cancer Res; 1998 Feb; 58(4):724-31. PubMed ID: 9485027
[TBL] [Abstract][Full Text] [Related]
43. Immune regulation through mitochondrion-dependent dendritic cell death induced by T regulatory cells.
Chen M; Felix K; Wang J
J Immunol; 2011 Dec; 187(11):5684-92. PubMed ID: 22031758
[TBL] [Abstract][Full Text] [Related]
44. LFA-1 defect-induced effector/memory CD8+ T cell apoptosis is mediated via Bcl-2/Caspase pathways and associated with downregulation of CD27 and IL-15R.
Ye Z; Shi M; Xu S; Xiang J
Mol Immunol; 2010 Aug; 47(14):2411-21. PubMed ID: 20569988
[TBL] [Abstract][Full Text] [Related]
45. CD40-targeted recombinant adenovirus significantly enhances the efficacy of antitumor vaccines based on dendritic cells and B cells.
Kim YS; Kim YJ; Lee JM; Han SH; Ko HJ; Park HJ; Pereboev A; Nguyen HH; Kang CY
Hum Gene Ther; 2010 Dec; 21(12):1697-706. PubMed ID: 20604681
[TBL] [Abstract][Full Text] [Related]
46. Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice.
Qian J; Dong Y; Pang YY; Ibrahim R; Berzofsky JA; Schiller JT; Khleif SN
Int J Cancer; 2006 Jun; 118(12):3022-9. PubMed ID: 16425257
[TBL] [Abstract][Full Text] [Related]
47. Blocking the immunosuppressive axis with small interfering RNA targeting interleukin (IL)-10 receptor enhances dendritic cell-based vaccine potency.
Kim JH; Kang TH; Noh KH; Bae HC; Ahn YH; Lee YH; Choi EY; Chun KH; Lee SJ; Kim TW
Clin Exp Immunol; 2011 Aug; 165(2):180-9. PubMed ID: 21592111
[TBL] [Abstract][Full Text] [Related]
48. Silencing invariant chain of DCs enhances Th1 response using small interfering RNA.
Ke S; Chen XH; Li H; Li JF; Gu QL; Liu BY; Zhu ZG
Cell Biol Int; 2007 Jul; 31(7):663-71. PubMed ID: 17296316
[TBL] [Abstract][Full Text] [Related]
49. Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1.
Lasaro MO; Diniz MO; Reyes-Sandoval A; Ertl HC; Ferreira LC
Microbes Infect; 2005 Dec; 7(15):1541-50. PubMed ID: 16213178
[TBL] [Abstract][Full Text] [Related]
50. Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity.
Wang TL; Ling M; Shih IM; Pham T; Pai SI; Lu Z; Kurman RJ; Pardoll DM; Wu TC
Gene Ther; 2000 May; 7(9):726-33. PubMed ID: 10822298
[TBL] [Abstract][Full Text] [Related]
51. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
52. CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model.
Kim TG; Kim CH; Won EH; Bae SM; Ahn WS; Park JB; Sin JI
Immunology; 2004 May; 112(1):117-25. PubMed ID: 15096191
[TBL] [Abstract][Full Text] [Related]
53. Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responses.
Báez-Astúa A; Herráez-Hernández E; Garbi N; Pasolli HA; Juárez V; Zur Hausen H; Cid-Arregui A
J Virol; 2005 Oct; 79(20):12807-17. PubMed ID: 16188983
[TBL] [Abstract][Full Text] [Related]
54. Enhancement of DNA vaccine potency by coadministration of a tumor antigen gene and DNA encoding serine protease inhibitor-6.
Kim TW; Hung CF; Boyd DA; He L; Lin CT; Kaiserman D; Bird PI; Wu TC
Cancer Res; 2004 Jan; 64(1):400-5. PubMed ID: 14729651
[TBL] [Abstract][Full Text] [Related]
55. Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination.
Kang TH; Lee JH; Song CK; Han HD; Shin BC; Pai SI; Hung CF; Trimble C; Lim JS; Kim TW; Wu TC
Cancer Res; 2007 Jan; 67(2):802-11. PubMed ID: 17234792
[TBL] [Abstract][Full Text] [Related]
56. A new development of FG-CC' siRNA blocking interaction of Tim-1 and Tim-4 can enhance DC vaccine against gastric cancer .
Sun HW; Wu C; Tan HY; Wang QS
Hepatogastroenterology; 2012; 59(120):2677-82. PubMed ID: 22709877
[TBL] [Abstract][Full Text] [Related]
57. Induction of CML28-specific cytotoxic T cell responses using co-transfected dendritic cells with CML28 DNA vaccine and SOCS1 small interfering RNA expression vector.
Zhou H; Zhang D; Wang Y; Dai M; Zhang L; Liu W; Liu D; Tan H; Huang Z
Biochem Biophys Res Commun; 2006 Aug; 347(1):200-7. PubMed ID: 16815301
[TBL] [Abstract][Full Text] [Related]
58. Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency.
Huang B; Mao CP; Peng S; He L; Hung CF; Wu TC
Vaccine; 2007 Nov; 25(45):7824-31. PubMed ID: 17931752
[TBL] [Abstract][Full Text] [Related]
59. A novel checkpoint in the Bcl-2-regulated apoptotic pathway revealed by murine cytomegalovirus infection of dendritic cells.
Andoniou CE; Andrews DM; Manzur M; Ricciardi-Castagnoli P; Degli-Esposti MA
J Cell Biol; 2004 Sep; 166(6):827-37. PubMed ID: 15353550
[TBL] [Abstract][Full Text] [Related]
60. RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potency.
Huang B; Mao CP; Peng S; Hung CF; Wu TC
Hum Gene Ther; 2008 Aug; 19(8):763-73. PubMed ID: 18627219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
